European R&D Job Vacancy Data Offer Corporate Insights
This article was originally published in Scrip
The UK and Germany accounted for just over half of all Pharma R&D vacancies in Europe last year, representing 29% of the total versus 25%, respectively, while Switzerland came in a distant third place with 12%, according to the recently published Vacancysoft/Clinical Professionals report on trends in life science R&D.
You may also be interested in...
Evotec’s multimodality approach to drug discovery landed the biotech two new discovery collaborations this week, underscoring its emphasis on patient-driven data.
Novo Nordisk and Evotec will identify and develop novel drugs for treating chronic kidney disease, using datasets of CKD patients provided by the Danish group and from other sources.
Sanofi is paying for $3.68bn cash for Principia to get the US biotech’s drug development platform and nascent pipeline, including a brain-penetrant BTK inhibitor in Phase III for multiple sclerosis.